| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | LHCGR VIPR1 OR9K2 HTR7 PTPRZ1 TAS2R36 OR13C2 PTCH2 OR2AG2 OR52E5 KIR2DS2 S1PR2 GRID1 C3AR1 ADGRF5 ROS1 RXFP1 KIR2DS1 PTCH1 KIR2DS4 OR6T1 KIR2DS5 ACKR4 KIR3DS1 KLRC4 OR6X1 CHRNB2 EDNRB GLP2R | 1.03e-12 | 1353 | 92 | 29 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GPR89B ATP8A1 SLC12A4 SLC17A3 ABCA12 SV2B SLC10A5 SLC38A4 SCN4A CLIC3 SCN9A NIPAL1 GPR89A GRID1 PANX2 SLC7A11 SLC4A5 ANKH CHRNB2 RYR1 ATP6V0A2 SLC5A1 | 1.34e-08 | 1180 | 92 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GPR89B ATP8A1 SLC12A4 SLC17A3 ABCA12 SV2B SLC10A5 SLC38A4 SCN4A CLIC3 SCN9A NIPAL1 GPR89A GRID1 PANX2 SLC7A11 SLC4A5 ANKH CHRNB2 RYR1 ATP6V0A2 SLC5A1 | 6.47e-08 | 1289 | 92 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GPR89B ATP8A1 SLC12A4 SLC17A3 SLC10A5 SLC38A4 SCN4A CLIC3 SCN9A NIPAL1 GPR89A GRID1 SLC4A5 CHRNB2 RYR1 ATP6V0A2 SLC5A1 | 1.11e-07 | 793 | 92 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | LHCGR VIPR1 OR9K2 HTR7 TAS2R36 OR13C2 OR2AG2 OR52E5 S1PR2 C3AR1 ADGRF5 RXFP1 OR6T1 ACKR4 OR6X1 EDNRB GLP2R | 5.12e-07 | 884 | 92 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP8A1 SLC12A4 SLC17A3 SLC10A5 SLC38A4 SCN4A SCN9A NIPAL1 SLC4A5 CHRNB2 RYR1 ATP6V0A2 SLC5A1 | 1.08e-05 | 664 | 92 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP8A1 SLC12A4 SLC17A3 ABCA12 SLC10A5 SLC38A4 SLC7A11 SLC4A5 ANKH ATP6V0A2 SLC5A1 | 1.21e-05 | 477 | 92 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.42e-05 | 171 | 92 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.85e-05 | 119 | 92 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | channel activity | GPR89B SLC12A4 SLC17A3 SCN4A CLIC3 SCN9A GPR89A GRID1 PANX2 CHRNB2 RYR1 | 2.94e-05 | 525 | 92 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GPR89B SLC12A4 SLC17A3 SCN4A CLIC3 SCN9A GPR89A GRID1 PANX2 CHRNB2 RYR1 | 2.99e-05 | 526 | 92 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 3.48e-05 | 133 | 92 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.62e-05 | 81 | 92 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A4 SLC17A3 SLC10A5 SLC38A4 SCN4A CLIC3 SCN9A NIPAL1 SLC4A5 ANKH RYR1 ATP6V0A2 SLC5A1 | 4.31e-05 | 758 | 92 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.64e-05 | 140 | 92 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A4 SLC17A3 SLC10A5 SLC38A4 SCN4A SCN9A NIPAL1 SLC4A5 RYR1 SLC5A1 | 5.58e-05 | 465 | 92 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 6.14e-05 | 17 | 92 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | hedgehog receptor activity | 6.28e-05 | 3 | 92 | 2 | GO:0008158 | |
| GeneOntologyMolecularFunction | phospholipase D activator activity | 6.28e-05 | 3 | 92 | 2 | GO:1990583 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 6.72e-05 | 296 | 92 | 8 | GO:0015291 | |
| GeneOntologyMolecularFunction | symporter activity | 6.81e-05 | 150 | 92 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 7.07e-05 | 151 | 92 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP8A1 SLC12A4 SLC17A3 SLC10A5 SLC38A4 SLC4A5 ATP6V0A2 SLC5A1 | 7.55e-05 | 301 | 92 | 8 | GO:0022853 |
| GeneOntologyMolecularFunction | hormone binding | 1.14e-04 | 103 | 92 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.15e-04 | 165 | 92 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 1.20e-04 | 55 | 92 | 4 | GO:0017046 | |
| GeneOntologyMolecularFunction | smoothened binding | 1.25e-04 | 4 | 92 | 2 | GO:0005119 | |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 1.25e-04 | 4 | 92 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A4 SLC17A3 SLC10A5 SLC38A4 SCN4A SCN9A NIPAL1 SLC4A5 RYR1 ATP6V0A2 SLC5A1 | 1.44e-04 | 627 | 92 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.66e-04 | 459 | 92 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.17e-03 | 171 | 92 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.32e-03 | 103 | 92 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.35e-03 | 293 | 92 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.42e-03 | 16 | 92 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 3.06e-03 | 18 | 92 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 3.06e-03 | 18 | 92 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 3.41e-03 | 19 | 92 | 2 | GO:0032394 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.48e-03 | 334 | 92 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 4.99e-03 | 23 | 92 | 2 | GO:0016004 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 5.43e-03 | 24 | 92 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | cyclase activity | 5.43e-03 | 24 | 92 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 5.88e-03 | 25 | 92 | 2 | GO:0016849 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | LHCGR GPR89B ATP8A1 EGF SLC12A4 SLC17A3 HTR7 SLC10A5 SLC38A4 SCN4A CLIC3 SCN9A NIPAL1 GPR89A GRID1 PANX2 SLC4A5 CHRNB2 RYR1 EDNRB ARF1 ATP6V0A2 SLC5A1 | 3.68e-08 | 1374 | 94 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 9.17e-08 | 3 | 94 | 3 | GO:0046544 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | LHCGR GPR89B ATP8A1 SLC12A4 SLC17A3 SLC38A4 SCN4A CLIC3 SCN9A NIPAL1 GPR89A GRID1 PANX2 SLC4A5 CHRNB2 RYR1 EDNRB ARF1 ATP6V0A2 SLC5A1 | 1.13e-07 | 1115 | 94 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | LHCGR ATP8A1 EGF SLC12A4 SLC17A3 SLC10A5 SLC38A4 SCN4A SCN9A NIPAL1 PANX2 SLC4A5 CHRNB2 RYR1 EDNRB ARF1 ATP6V0A2 SLC5A1 | 4.12e-06 | 1157 | 94 | 18 | GO:0006812 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC17A3 SLC10A5 SLC38A4 SCN4A SCN9A SLC4A5 EDNRB ARF1 SLC5A1 | 4.62e-06 | 275 | 94 | 9 | GO:0006814 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 6.35e-06 | 286 | 94 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 6.42e-06 | 153 | 94 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 7.28e-06 | 59 | 94 | 5 | GO:0045761 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | SGPP1 RIPOR2 ABCA12 TMEM132E SIPA1L3 PTCH2 S1PR2 ROS1 TECTA PTCH1 SLC7A11 SLC4A5 EDNRB STAT5A STAT5B | 8.72e-06 | 870 | 94 | 15 | GO:0030855 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | LHCGR VIPR1 OR9K2 HTR7 TAS2R36 OR13C2 OR2AG2 OR52E5 S1PR2 C3AR1 ADGRF5 RXFP1 OR6T1 ACKR4 ADCY2 ADCY5 OR6X1 EDNRB GLP2R | 1.44e-05 | 1395 | 94 | 19 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.58e-05 | 69 | 94 | 5 | GO:0031279 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 1.69e-05 | 34 | 94 | 4 | GO:0007190 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.85e-05 | 180 | 94 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.06e-05 | 183 | 94 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 2.08e-05 | 73 | 94 | 5 | GO:0051339 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 2.54e-05 | 13 | 94 | 3 | GO:0045136 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2.71e-05 | 191 | 94 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 3.26e-05 | 40 | 94 | 4 | GO:0045762 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | LHCGR GPR89B TMEM174 SLC12A4 ABCA12 SV2B GPR89A ADGRF5 PTCH1 SLC7A11 SLC4A5 ANKH ADCY5 RYR1 EDNRB ARF1 ATP6V0A2 | 4.41e-05 | 1249 | 94 | 17 | GO:0048878 |
| GeneOntologyBiologicalProcess | metal ion transport | LHCGR EGF SLC12A4 SLC17A3 SLC10A5 SLC38A4 SCN4A SCN9A NIPAL1 SLC4A5 CHRNB2 RYR1 EDNRB ARF1 SLC5A1 | 4.43e-05 | 1000 | 94 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.67e-05 | 208 | 94 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 4.78e-05 | 44 | 94 | 4 | GO:0002717 | |
| GeneOntologyBiologicalProcess | behavior | DPP4 PIANP ATP8A1 HTR7 PTPRZ1 SCN9A GRID1 SLC7A11 ANKH ADCY5 SLITRK1 CHRNB2 EDNRB ARF4 | 4.97e-05 | 891 | 94 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | LHCGR SLC12A4 SLC17A3 SLC38A4 SCN4A CLIC3 SCN9A NIPAL1 SLC4A5 ANKH RYR1 EDNRB ARF1 ATP6V0A2 SLC5A1 | 5.36e-05 | 1017 | 94 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 6.11e-05 | 217 | 94 | 7 | GO:0030856 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 6.75e-05 | 48 | 94 | 4 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 7.32e-05 | 49 | 94 | 4 | GO:0051349 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | LHCGR ATP8A1 SLC12A4 SLC17A3 SLC38A4 SCN4A SCN9A NIPAL1 SLC4A5 RYR1 EDNRB ARF1 ATP6V0A2 SLC5A1 | 9.02e-05 | 942 | 94 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of neutrophil migration | 1.52e-04 | 59 | 94 | 4 | GO:1902622 | |
| GeneOntologyBiologicalProcess | regulation of epidermal cell differentiation | 1.96e-04 | 63 | 94 | 4 | GO:0045604 | |
| GeneOntologyBiologicalProcess | vein smooth muscle contraction | 2.04e-04 | 5 | 94 | 2 | GO:0014826 | |
| GeneOntologyBiologicalProcess | regulation of pH | 2.23e-04 | 120 | 94 | 5 | GO:0006885 | |
| GeneOntologyBiologicalProcess | lipid localization | SGPP1 LHCGR ATP8A1 EGF ABCA12 SLC10A5 VPS13C PTCH1 STAT5A STAT5B | 2.52e-04 | 565 | 94 | 10 | GO:0010876 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | LHCGR SLC12A4 SLC17A3 SLC38A4 SCN4A SCN9A NIPAL1 SLC4A5 RYR1 EDNRB ARF1 ATP6V0A2 SLC5A1 | 2.75e-04 | 922 | 94 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | epidermal cell fate specification | 3.05e-04 | 6 | 94 | 2 | GO:0009957 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 3.11e-04 | 71 | 94 | 4 | GO:0045682 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 3.21e-04 | 284 | 94 | 7 | GO:0009913 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | LHCGR GPR89B SLC12A4 SV2B GPR89A SLC4A5 ANKH RYR1 EDNRB ARF1 ATP6V0A2 | 3.61e-04 | 705 | 94 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | phosphate ion transport | 3.76e-04 | 31 | 94 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | regulation of immune response | DPP4 CD1B PIANP KIR2DS2 C3AR1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 ADAM8 KLRC4 STAT5A STAT5B | 3.88e-04 | 1085 | 94 | 14 | GO:0050776 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | LHCGR GPR89B SLC12A4 SV2B GPR89A SLC4A5 ANKH RYR1 EDNRB ARF1 ATP6V0A2 | 4.16e-04 | 717 | 94 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 4.68e-04 | 79 | 94 | 4 | GO:0001912 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 4.91e-04 | 80 | 94 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | LHCGR GPR89B SLC12A4 ABCA12 SV2B GPR89A SLC7A11 SLC4A5 ANKH ADCY5 RYR1 ARF1 ATP6V0A2 | 4.97e-04 | 981 | 94 | 13 | GO:0019725 |
| GeneOntologyBiologicalProcess | renal system process | 6.02e-04 | 149 | 94 | 5 | GO:0003014 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 6.21e-04 | 150 | 94 | 5 | GO:0002708 | |
| GeneOntologyBiologicalProcess | cognition | 7.00e-04 | 423 | 94 | 8 | GO:0050890 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 7.04e-04 | 88 | 94 | 4 | GO:0031343 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 7.25e-04 | 9 | 94 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 7.25e-04 | 9 | 94 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 8.01e-04 | 40 | 94 | 3 | GO:0045954 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil chemotaxis | 8.62e-04 | 41 | 94 | 3 | GO:0090022 | |
| GeneOntologyBiologicalProcess | mammary gland development | 8.79e-04 | 162 | 94 | 5 | GO:0030879 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 9.02e-04 | 94 | 94 | 4 | GO:0051453 | |
| GeneOntologyBiologicalProcess | negative regulation of action potential | 9.03e-04 | 10 | 94 | 2 | GO:0045759 | |
| GeneOntologyBiologicalProcess | positive regulation of neutrophil extravasation | 9.03e-04 | 10 | 94 | 2 | GO:2000391 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 9.03e-04 | 10 | 94 | 2 | GO:0060397 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 9.03e-04 | 10 | 94 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell apoptotic process | 9.25e-04 | 42 | 94 | 3 | GO:0033032 | |
| GeneOntologyBiologicalProcess | epithelium development | SGPP1 RIPOR2 EGF ABCA12 TMEM132E SIPA1L3 PTCH2 S1PR2 ROS1 TECTA PTCH1 SLC7A11 SLC4A5 EDNRB STAT5A STAT5B | 9.30e-04 | 1469 | 94 | 16 | GO:0060429 |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 1.10e-03 | 11 | 94 | 2 | GO:0006171 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil extravasation | 1.10e-03 | 11 | 94 | 2 | GO:2000389 | |
| GeneOntologyBiologicalProcess | negative regulation of erythrocyte differentiation | 1.10e-03 | 11 | 94 | 2 | GO:0045647 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 1.10e-03 | 11 | 94 | 2 | GO:0070669 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.18e-03 | 101 | 94 | 4 | GO:0030641 | |
| GeneOntologyBiologicalProcess | epidermis development | 1.22e-03 | 461 | 94 | 8 | GO:0008544 | |
| GeneOntologyBiologicalProcess | secretion | LHCGR PIANP EGF HTR7 ABCA12 SV2B ADAM8 SLC4A5 ADCY5 CHRNB2 EDNRB ARF1 STAT5A STAT5B | 1.23e-03 | 1221 | 94 | 14 | GO:0046903 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 1.24e-03 | 175 | 94 | 5 | GO:0002705 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 1.26e-03 | 358 | 94 | 7 | GO:0015850 | |
| GeneOntologyBiologicalProcess | positive regulation of neutrophil migration | 1.29e-03 | 47 | 94 | 3 | GO:1902624 | |
| GeneOntologyBiologicalProcess | epithelial fluid transport | 1.32e-03 | 12 | 94 | 2 | GO:0042045 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 1.32e-03 | 12 | 94 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 1.32e-03 | 12 | 94 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 1.32e-03 | 12 | 94 | 2 | GO:0070672 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 1.35e-03 | 582 | 94 | 9 | GO:0050906 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 1.45e-03 | 269 | 94 | 6 | GO:0002064 | |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 1.55e-03 | 13 | 94 | 2 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 1.55e-03 | 13 | 94 | 2 | GO:0048541 | |
| GeneOntologyBiologicalProcess | response to sodium phosphate | 1.55e-03 | 13 | 94 | 2 | GO:1904383 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.56e-03 | 109 | 94 | 4 | GO:0002228 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | GPR89B DPP4 RIPOR2 BST2 GPR89A KIR3DS1 ADAM8 WDFY4 KLRC4 CHRNB2 STAT5A STAT5B | 1.58e-03 | 976 | 94 | 12 | GO:0046649 |
| GeneOntologyBiologicalProcess | learning or memory | 1.59e-03 | 373 | 94 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | myeloid cell apoptotic process | 1.63e-03 | 51 | 94 | 3 | GO:0033028 | |
| GeneOntologyBiologicalProcess | response to pain | 1.63e-03 | 51 | 94 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte migration | 1.66e-03 | 276 | 94 | 6 | GO:0097529 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 1.80e-03 | 14 | 94 | 2 | GO:0046645 | |
| GeneOntologyBiologicalProcess | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 1.82e-03 | 53 | 94 | 3 | GO:0006890 | |
| GeneOntologyCellularComponent | apical part of cell | DPP4 TMEM174 RIPOR2 SLC17A3 BST2 SIPA1L3 BYSL ADGRF5 PTCH1 SLC7A11 SLC4A5 SLC5A1 | 1.37e-05 | 592 | 94 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | cell projection membrane | DPP4 RIPOR2 SLC17A3 PTPRZ1 SLC38A4 PTCH1 SLC7A11 ARF4 SLC5A1 | 1.40e-04 | 431 | 94 | 9 | GO:0031253 |
| GeneOntologyCellularComponent | lysosomal membrane | 2.35e-04 | 462 | 94 | 9 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.35e-04 | 462 | 94 | 9 | GO:0098852 | |
| GeneOntologyCellularComponent | vacuolar membrane | 4.63e-04 | 507 | 94 | 9 | GO:0005774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GPR89B CD1B ATP8A1 EGF ABCA12 SV2B BST2 VPS13C GPR89A PAM C3AR1 PTCH1 KIR2DS4 ADAM8 ATP6V0A2 | 7.03e-04 | 1307 | 94 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | secretory granule membrane | 7.12e-04 | 329 | 94 | 7 | GO:0030667 | |
| GeneOntologyCellularComponent | vacuole | DPP4 CD1B STS ATP8A1 EGF SLC12A4 BST2 VPS13C ACR C3AR1 ADAM8 ATP6V0A2 | 7.94e-04 | 913 | 94 | 12 | GO:0005773 |
| GeneOntologyCellularComponent | vesicle membrane | GPR89B CD1B ATP8A1 EGF ABCA12 SV2B BST2 VPS13C GPR89A PAM C3AR1 PTCH1 KIR2DS4 ADAM8 ATP6V0A2 | 8.09e-04 | 1325 | 94 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | transporter complex | 8.28e-04 | 550 | 94 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | dense core granule membrane | 8.79e-04 | 10 | 94 | 2 | GO:0032127 | |
| GeneOntologyCellularComponent | lysosome | DPP4 CD1B STS ATP8A1 EGF SLC12A4 BST2 VPS13C C3AR1 ADAM8 ATP6V0A2 | 1.03e-03 | 811 | 94 | 11 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | DPP4 CD1B STS ATP8A1 EGF SLC12A4 BST2 VPS13C C3AR1 ADAM8 ATP6V0A2 | 1.03e-03 | 811 | 94 | 11 | GO:0000323 |
| GeneOntologyCellularComponent | apical plasma membrane | 1.58e-03 | 487 | 94 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.59e-03 | 378 | 94 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.75e-03 | 114 | 94 | 4 | GO:0005798 | |
| GeneOntologyCellularComponent | secretory granule | ATP8A1 EGF ABCA12 SV2B BST2 VPS13C ACR PAM C3AR1 ADAM8 F13A1 ATP6V0A2 | 1.94e-03 | 1014 | 94 | 12 | GO:0030141 |
| GeneOntologyCellularComponent | azurophil granule membrane | 2.39e-03 | 59 | 94 | 3 | GO:0035577 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.47e-03 | 523 | 94 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.60e-03 | 17 | 94 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | secretory vesicle | ATP8A1 EGF HTR7 ABCA12 SV2B BST2 VPS13C ACR PAM C3AR1 ADAM8 F13A1 ATP6V0A2 | 3.76e-03 | 1246 | 94 | 13 | GO:0099503 |
| GeneOntologyCellularComponent | cell surface | BOC DPP4 CD1B BST2 PAM ADGRF5 ROS1 ACKR4 ADAM8 SLC7A11 KLRC4 CHRNB2 | 4.09e-03 | 1111 | 94 | 12 | GO:0009986 |
| Domain | ig | 4.82e-06 | 190 | 93 | 8 | PF00047 | |
| Domain | Immunoglobulin | 4.82e-06 | 190 | 93 | 8 | IPR013151 | |
| Domain | ARF | 1.24e-05 | 29 | 93 | 4 | PS51417 | |
| Domain | Small_GTPase_ARF | 1.24e-05 | 29 | 93 | 4 | IPR024156 | |
| Domain | Arf | 1.64e-05 | 31 | 93 | 4 | PF00025 | |
| Domain | Small_GTPase_ARF/SAR | 2.11e-05 | 33 | 93 | 4 | IPR006689 | |
| Domain | TM_rcpt_patched | 2.45e-05 | 2 | 93 | 2 | IPR004766 | |
| Domain | 7tm_1 | LHCGR OR9K2 HTR7 OR13C2 OR2AG2 OR52E5 S1PR2 C3AR1 RXFP1 OR6T1 ACKR4 OR6X1 EDNRB | 2.99e-05 | 677 | 93 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | LHCGR OR9K2 HTR7 OR13C2 OR2AG2 OR52E5 S1PR2 C3AR1 RXFP1 OR6T1 ACKR4 OR6X1 EDNRB | 3.38e-05 | 685 | 93 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | LHCGR OR9K2 HTR7 OR13C2 OR2AG2 OR52E5 S1PR2 C3AR1 RXFP1 OR6T1 ACKR4 OR6X1 EDNRB | 3.70e-05 | 691 | 93 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | LHCGR OR9K2 HTR7 OR13C2 OR2AG2 OR52E5 S1PR2 C3AR1 RXFP1 OR6T1 ACKR4 OR6X1 EDNRB | 3.75e-05 | 692 | 93 | 13 | IPR000276 |
| Domain | Ig-like_fold | BOC LRIT2 CD1B PTPRZ1 KIR2DS2 ADGRF5 ROS1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 F13A1 | 4.61e-05 | 706 | 93 | 13 | IPR013783 |
| Domain | - | BOC LRIT2 CD1B PTPRZ1 KIR2DS2 ADGRF5 ROS1 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DS1 F13A1 | 1.09e-04 | 663 | 93 | 12 | 2.60.40.10 |
| Domain | GPCR_Rhodpsn_7TM | LHCGR OR9K2 HTR7 OR13C2 OR2AG2 S1PR2 C3AR1 RXFP1 OR6T1 ACKR4 OR6X1 EDNRB | 1.20e-04 | 670 | 93 | 12 | IPR017452 |
| Domain | Ig-like_dom | BOC LRIT2 CD1B KIR2DS2 ADGRF5 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 | 2.01e-04 | 503 | 93 | 10 | IPR007110 |
| Domain | IG | BOC LRIT2 KIR2DS2 ADGRF5 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 | 2.49e-04 | 421 | 93 | 9 | SM00409 |
| Domain | Ig_sub | BOC LRIT2 KIR2DS2 ADGRF5 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 | 2.49e-04 | 421 | 93 | 9 | IPR003599 |
| Domain | Adcy_conserved_dom | 3.63e-04 | 6 | 93 | 2 | IPR009398 | |
| Domain | DUF1053 | 3.63e-04 | 6 | 93 | 2 | PF06327 | |
| Domain | STAT_TF_prot_interaction | 5.07e-04 | 7 | 93 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 5.07e-04 | 7 | 93 | 2 | IPR012345 | |
| Domain | STAT | 5.07e-04 | 7 | 93 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 5.07e-04 | 7 | 93 | 2 | IPR015988 | |
| Domain | - | 5.07e-04 | 7 | 93 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 5.07e-04 | 7 | 93 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 5.07e-04 | 7 | 93 | 2 | IPR013801 | |
| Domain | STAT_bind | 5.07e-04 | 7 | 93 | 2 | PF02864 | |
| Domain | STAT_int | 5.07e-04 | 7 | 93 | 2 | PF02865 | |
| Domain | - | 5.07e-04 | 7 | 93 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 5.07e-04 | 7 | 93 | 2 | PF01017 | |
| Domain | - | 5.07e-04 | 7 | 93 | 2 | 1.20.1050.20 | |
| Domain | GPCR_2_secretin-like_CS | 6.40e-04 | 34 | 93 | 3 | IPR017983 | |
| Domain | STAT_TF_alpha | 6.74e-04 | 8 | 93 | 2 | IPR013800 | |
| Domain | AC_N | 6.74e-04 | 8 | 93 | 2 | IPR032628 | |
| Domain | Adcy | 6.74e-04 | 8 | 93 | 2 | IPR030672 | |
| Domain | AC_N | 6.74e-04 | 8 | 93 | 2 | PF16214 | |
| Domain | IG_LIKE | BOC LRIT2 CD1B KIR2DS2 ADGRF5 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 | 7.59e-04 | 491 | 93 | 9 | PS50835 |
| Domain | Ptc/Disp | 8.63e-04 | 9 | 93 | 2 | IPR003392 | |
| Domain | Patched | 8.63e-04 | 9 | 93 | 2 | PF02460 | |
| Domain | - | 9.59e-04 | 39 | 93 | 3 | 2.120.10.30 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.03e-03 | 40 | 93 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.03e-03 | 40 | 93 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.03e-03 | 40 | 93 | 3 | PS50227 | |
| Domain | Na_channel_asu | 1.08e-03 | 10 | 93 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.08e-03 | 10 | 93 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.08e-03 | 10 | 93 | 2 | PF06512 | |
| Domain | LRRNT | 1.46e-03 | 98 | 93 | 4 | IPR000372 | |
| Domain | LRRNT | 1.46e-03 | 98 | 93 | 4 | SM00013 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.55e-03 | 46 | 93 | 3 | IPR011042 | |
| Domain | SSD | 1.85e-03 | 13 | 93 | 2 | IPR000731 | |
| Domain | SSD | 1.85e-03 | 13 | 93 | 2 | PS50156 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.98e-03 | 50 | 93 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.98e-03 | 50 | 93 | 3 | PF00002 | |
| Domain | LY | 2.47e-03 | 15 | 93 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.47e-03 | 15 | 93 | 2 | IPR000033 | |
| Domain | Disintegrin_CS | 2.81e-03 | 16 | 93 | 2 | IPR018358 | |
| Domain | A/G_cyclase_CS | 3.18e-03 | 17 | 93 | 2 | IPR018297 | |
| Domain | GPCR_2_secretin-like | 3.33e-03 | 60 | 93 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 3.33e-03 | 60 | 93 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.49e-03 | 61 | 93 | 3 | PS50261 | |
| Domain | Nucleotide_cyclase | 3.56e-03 | 18 | 93 | 2 | IPR029787 | |
| Domain | ADAM_CR | 3.56e-03 | 18 | 93 | 2 | PF08516 | |
| Domain | - | 3.56e-03 | 18 | 93 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 3.97e-03 | 19 | 93 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 3.97e-03 | 19 | 93 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 3.97e-03 | 19 | 93 | 2 | PS50125 | |
| Domain | A/G_cyclase | 3.97e-03 | 19 | 93 | 2 | IPR001054 | |
| Domain | CYCc | 3.97e-03 | 19 | 93 | 2 | SM00044 | |
| Domain | - | 4.40e-03 | 20 | 93 | 2 | 4.10.70.10 | |
| Domain | MAGE_N | 4.40e-03 | 20 | 93 | 2 | SM01392 | |
| Domain | Disintegrin | 4.84e-03 | 21 | 93 | 2 | PF00200 | |
| Domain | DISIN | 4.84e-03 | 21 | 93 | 2 | SM00050 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.41e-06 | 272 | 81 | 10 | M13380 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 6.29e-06 | 7 | 81 | 3 | M27501 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 6.29e-06 | 7 | 81 | 3 | M47430 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 6.30e-06 | 46 | 81 | 5 | M27151 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR | 1.50e-05 | 9 | 81 | 3 | M47893 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8A1 SLC12A4 SLC17A3 ABCA12 SLC38A4 NIPAL1 SLC7A11 SLC4A5 ANKH ADCY2 ADCY5 RYR1 ARF1 ATP6V0A2 SLC5A1 | 1.64e-05 | 736 | 81 | 15 | M27287 |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 3.24e-05 | 157 | 81 | 7 | M4904 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | LHCGR VIPR1 HTR7 PTCH2 S1PR2 C3AR1 RXFP1 PTCH1 ACKR4 EDNRB GLP2R | 6.49e-05 | 463 | 81 | 11 | M507 |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 9.70e-05 | 16 | 81 | 3 | M47645 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8A1 SLC12A4 SLC17A3 ABCA12 SLC38A4 NIPAL1 SLC7A11 SLC4A5 ANKH RYR1 ARF1 ATP6V0A2 SLC5A1 | 1.25e-04 | 681 | 81 | 13 | MM14985 |
| Pathway | WP_GPCRS_NONODORANT | 1.42e-04 | 266 | 81 | 8 | MM15843 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.49e-04 | 88 | 81 | 5 | M16004 | |
| Pathway | WP_GPCRS_ORPHAN | 1.66e-04 | 19 | 81 | 3 | MM15991 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LHCGR VIPR1 HTR7 PTCH2 S1PR2 C3AR1 RXFP1 PTCH1 ACKR4 ADCY2 ADCY5 EDNRB GLP2R | 1.69e-04 | 702 | 81 | 13 | M746 |
| Pathway | PID_HEDGEHOG_2PATHWAY | 2.60e-04 | 22 | 81 | 3 | M211 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.22e-04 | 5 | 81 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.22e-04 | 5 | 81 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.22e-04 | 5 | 81 | 2 | M49006 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.82e-04 | 6 | 81 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 4.82e-04 | 6 | 81 | 2 | MM15621 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 6.72e-04 | 7 | 81 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 6.72e-04 | 7 | 81 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 6.72e-04 | 7 | 81 | 2 | M47646 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 6.72e-04 | 7 | 81 | 2 | M27907 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 7.85e-04 | 430 | 81 | 9 | MM15160 | |
| Pathway | REACTOME_LIGAND_RECEPTOR_INTERACTIONS | 8.93e-04 | 8 | 81 | 2 | M27496 | |
| Pathway | WP_PEPTIDE_GPCRS | 9.02e-04 | 75 | 81 | 4 | M39696 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LHCGR VIPR1 HTR7 S1PR2 C3AR1 RXFP1 ACKR4 ADCY2 ADCY5 EDNRB GLP2R | 1.12e-03 | 646 | 81 | 11 | MM14962 |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.14e-03 | 9 | 81 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.14e-03 | 9 | 81 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.14e-03 | 9 | 81 | 2 | M8066 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.38e-03 | 143 | 81 | 5 | MM15055 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.42e-03 | 10 | 81 | 2 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.42e-03 | 10 | 81 | 2 | MM14668 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.42e-03 | 10 | 81 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.42e-03 | 10 | 81 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.42e-03 | 10 | 81 | 2 | MM15618 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.71e-03 | 150 | 81 | 5 | M27440 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.73e-03 | 11 | 81 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.73e-03 | 11 | 81 | 2 | MM15578 | |
| Pathway | PID_TCPTP_PATHWAY | 1.79e-03 | 42 | 81 | 3 | M91 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.91e-03 | 43 | 81 | 3 | M39706 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.07e-03 | 12 | 81 | 2 | M27893 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 2.08e-03 | 94 | 81 | 4 | M797 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.43e-03 | 98 | 81 | 4 | MM15352 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4 | 2.44e-03 | 13 | 81 | 2 | M39582 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.61e-03 | 100 | 81 | 4 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.81e-03 | 102 | 81 | 4 | M27648 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 2.84e-03 | 14 | 81 | 2 | M47414 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 2.84e-03 | 14 | 81 | 2 | MM14669 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.84e-03 | 14 | 81 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 2.84e-03 | 14 | 81 | 2 | M135 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 2.84e-03 | 14 | 81 | 2 | M750 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.86e-03 | 330 | 81 | 7 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 3.00e-03 | 333 | 81 | 7 | MM14963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 3.26e-03 | 15 | 81 | 2 | M47794 | |
| Pathway | WP_FOXP3_IN_COVID19 | 3.26e-03 | 15 | 81 | 2 | M42573 | |
| Pathway | SA_G1_AND_S_PHASES | 3.26e-03 | 15 | 81 | 2 | M1529 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 3.26e-03 | 15 | 81 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 3.26e-03 | 15 | 81 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 3.26e-03 | 15 | 81 | 2 | M17681 | |
| Pathway | PID_LPA4_PATHWAY | 3.26e-03 | 15 | 81 | 2 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 3.26e-03 | 15 | 81 | 2 | M47504 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 3.26e-03 | 15 | 81 | 2 | MM14536 | |
| Pathway | PID_PTP1B_PATHWAY | 3.30e-03 | 52 | 81 | 3 | M50 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.45e-03 | 108 | 81 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.56e-03 | 109 | 81 | 4 | MM15074 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.59e-03 | 178 | 81 | 5 | M2890 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 3.68e-03 | 110 | 81 | 4 | MM15350 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 3.71e-03 | 16 | 81 | 2 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.71e-03 | 16 | 81 | 2 | MM14492 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.71e-03 | 16 | 81 | 2 | MM15710 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 3.71e-03 | 16 | 81 | 2 | M39675 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.71e-03 | 16 | 81 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.71e-03 | 16 | 81 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 3.71e-03 | 16 | 81 | 2 | M41733 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 3.71e-03 | 16 | 81 | 2 | M39849 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 4.19e-03 | 17 | 81 | 2 | M26995 | |
| Pathway | WP_IL9_SIGNALING | 4.19e-03 | 17 | 81 | 2 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 4.19e-03 | 17 | 81 | 2 | M47544 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 4.19e-03 | 17 | 81 | 2 | M47905 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.32e-03 | 186 | 81 | 5 | MM15994 | |
| Pathway | REACTOME_ACTIVATION_OF_SMO | 4.70e-03 | 18 | 81 | 2 | M27500 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 4.70e-03 | 18 | 81 | 2 | M673 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 4.70e-03 | 18 | 81 | 2 | M7552 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 4.70e-03 | 18 | 81 | 2 | M645 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 4.70e-03 | 18 | 81 | 2 | MM14642 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 4.70e-03 | 18 | 81 | 2 | MM1479 | |
| Pubmed | 1.37e-13 | 5 | 95 | 5 | 19410616 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 1.62e-13 | 11 | 95 | 6 | 19664392 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 20371502 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 3.23e-13 | 12 | 95 | 6 | 19181658 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 20137308 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 19934297 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 19120281 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 18687225 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 19875891 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 1.04e-12 | 14 | 95 | 6 | 19421224 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.04e-12 | 14 | 95 | 6 | 15896204 | |
| Pubmed | 1.74e-12 | 15 | 95 | 6 | 20082646 | ||
| Pubmed | 1.74e-12 | 15 | 95 | 6 | 19850842 | ||
| Pubmed | 1.74e-12 | 15 | 95 | 6 | 20356536 | ||
| Pubmed | 1.74e-12 | 15 | 95 | 6 | 19926642 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 1.74e-12 | 15 | 95 | 6 | 20207982 | |
| Pubmed | 1.74e-12 | 15 | 95 | 6 | 19493232 | ||
| Pubmed | 1.74e-12 | 15 | 95 | 6 | 20643584 | ||
| Pubmed | 1.74e-12 | 15 | 95 | 6 | 19326408 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 19897003 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 19000141 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 20670355 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 18668235 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 19309280 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 2.77e-12 | 16 | 95 | 6 | 19527230 | |
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 20652381 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 19279038 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 17868255 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 18643961 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 20331834 | ||
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 20210919 | ||
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 19968064 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 4.27e-12 | 17 | 95 | 6 | 20878400 | |
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 20650299 | ||
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 20173784 | ||
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 20173792 | ||
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 20483367 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 4.27e-12 | 17 | 95 | 6 | 19218127 | |
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 19169284 | ||
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 19450876 | ||
| Pubmed | 4.27e-12 | 17 | 95 | 6 | 19761533 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 6.40e-12 | 18 | 95 | 6 | 19630074 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 6.40e-12 | 18 | 95 | 6 | 19046302 | |
| Pubmed | 6.40e-12 | 18 | 95 | 6 | 20580654 | ||
| Pubmed | 6.40e-12 | 18 | 95 | 6 | 20519398 | ||
| Pubmed | 6.40e-12 | 18 | 95 | 6 | 19846535 | ||
| Pubmed | 7.60e-12 | 8 | 95 | 5 | 18681957 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 9.33e-12 | 19 | 95 | 6 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 9.33e-12 | 19 | 95 | 6 | 18778326 | |
| Pubmed | 9.33e-12 | 19 | 95 | 6 | 20600442 | ||
| Pubmed | 9.33e-12 | 19 | 95 | 6 | 18848853 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 1.33e-11 | 20 | 95 | 6 | 20193031 | |
| Pubmed | 1.33e-11 | 20 | 95 | 6 | 20426625 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 1.71e-11 | 9 | 95 | 5 | 8662091 | |
| Pubmed | 1.71e-11 | 9 | 95 | 5 | 18340360 | ||
| Pubmed | 1.86e-11 | 21 | 95 | 6 | 19861144 | ||
| Pubmed | 2.55e-11 | 22 | 95 | 6 | 20492596 | ||
| Pubmed | 3.41e-11 | 10 | 95 | 5 | 21206914 | ||
| Pubmed | 6.23e-11 | 11 | 95 | 5 | 18830515 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 1.60e-10 | 29 | 95 | 6 | 20082482 | |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 2.61e-10 | 5 | 95 | 4 | 2105501 | |
| Pubmed | 2.68e-10 | 14 | 95 | 5 | 19489269 | ||
| Pubmed | 2.68e-10 | 14 | 95 | 5 | 18945962 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 4.02e-10 | 15 | 95 | 5 | 17498266 | |
| Pubmed | 5.39e-10 | 35 | 95 | 6 | 19683555 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 5.83e-10 | 16 | 95 | 5 | 16403292 | |
| Pubmed | 7.80e-10 | 6 | 95 | 4 | 20528243 | ||
| Pubmed | 7.80e-10 | 6 | 95 | 4 | 17882223 | ||
| Pubmed | 8.24e-10 | 17 | 95 | 5 | 19032228 | ||
| Pubmed | 1.14e-09 | 18 | 95 | 5 | 20200544 | ||
| Pubmed | 1.14e-09 | 18 | 95 | 5 | 20210918 | ||
| Pubmed | 3.63e-09 | 8 | 95 | 4 | 8947846 | ||
| Pubmed | 3.63e-09 | 8 | 95 | 4 | 8195219 | ||
| Pubmed | 6.51e-09 | 9 | 95 | 4 | 7749980 | ||
| Pubmed | 6.51e-09 | 9 | 95 | 4 | 18074414 | ||
| Pubmed | 1.08e-08 | 10 | 95 | 4 | 12559621 | ||
| Pubmed | 1.08e-08 | 10 | 95 | 4 | 10828067 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 1447192 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 8765026 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 19500138 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with pulmonary tuberculosis in Chinese Han. | 1.97e-08 | 3 | 95 | 3 | 22653583 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 23783033 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 23325834 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 29408295 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 2.54e-08 | 12 | 95 | 4 | 17490516 | |
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 8491770 | ||
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 25253288 | ||
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 21233146 | ||
| Pubmed | Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. | 7.88e-08 | 4 | 95 | 3 | 23394822 | |
| Pubmed | A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis. | 7.88e-08 | 4 | 95 | 3 | 16829306 | |
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 9038142 | ||
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 16698429 | ||
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 26472014 | ||
| Pubmed | Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. | 1.97e-07 | 5 | 95 | 3 | 10424431 | |
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 22729867 | ||
| Pubmed | An Arf/Rab cascade controls the growth and invasiveness of glioblastoma. | 3.93e-07 | 6 | 95 | 3 | 33443570 | |
| Pubmed | WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. | 3.93e-07 | 6 | 95 | 3 | 24768165 | |
| Pubmed | 6.86e-07 | 7 | 95 | 3 | 14607943 | ||
| Pubmed | 6.86e-07 | 7 | 95 | 3 | 11950392 | ||
| Interaction | B4GALT7 interactions | 1.37e-05 | 70 | 88 | 5 | int:B4GALT7 | |
| Interaction | GPR89A interactions | 1.43e-05 | 120 | 88 | 6 | int:GPR89A | |
| Interaction | KIR2DS2 interactions | 2.01e-05 | 37 | 88 | 4 | int:KIR2DS2 | |
| Interaction | ALG9 interactions | 2.18e-05 | 77 | 88 | 5 | int:ALG9 | |
| Interaction | KIR2DL2 interactions | 2.23e-05 | 13 | 88 | 3 | int:KIR2DL2 | |
| Interaction | PDXDC1 interactions | 3.53e-05 | 208 | 88 | 7 | int:PDXDC1 | |
| Interaction | KIR2DS5 interactions | 4.32e-05 | 16 | 88 | 3 | int:KIR2DS5 | |
| Interaction | GOLGA5 interactions | 4.76e-05 | 218 | 88 | 7 | int:GOLGA5 | |
| Interaction | MAN1A2 interactions | 5.70e-05 | 48 | 88 | 4 | int:MAN1A2 | |
| Interaction | PPM1L interactions | 6.26e-05 | 18 | 88 | 3 | int:PPM1L | |
| Interaction | SHH interactions | 6.26e-05 | 18 | 88 | 3 | int:SHH | |
| Interaction | TRIP11 interactions | 6.73e-05 | 158 | 88 | 6 | int:TRIP11 | |
| Interaction | KIR2DS3 interactions | 8.69e-05 | 20 | 88 | 3 | int:KIR2DS3 | |
| Interaction | HS6ST2 interactions | 9.09e-05 | 54 | 88 | 4 | int:HS6ST2 | |
| Interaction | AP4E1 interactions | 9.09e-05 | 54 | 88 | 4 | int:AP4E1 | |
| Interaction | NETO2 interactions | 9.77e-05 | 55 | 88 | 4 | int:NETO2 | |
| Interaction | DENND1B interactions | 1.01e-04 | 21 | 88 | 3 | int:DENND1B | |
| Interaction | CNNM1 interactions | 1.05e-04 | 56 | 88 | 4 | int:CNNM1 | |
| Interaction | KIR3DP1 interactions | 1.12e-04 | 4 | 88 | 2 | int:KIR3DP1 | |
| Interaction | KIR2DS1 interactions | 1.12e-04 | 4 | 88 | 2 | int:KIR2DS1 | |
| Interaction | ARFGAP3 interactions | 1.16e-04 | 109 | 88 | 5 | int:ARFGAP3 | |
| Interaction | POMT2 interactions | 1.37e-04 | 60 | 88 | 4 | int:POMT2 | |
| Interaction | YIPF3 interactions | 1.65e-04 | 186 | 88 | 6 | int:YIPF3 | |
| Interaction | ADAM32 interactions | 1.95e-04 | 26 | 88 | 3 | int:ADAM32 | |
| Interaction | AGPAT4 interactions | 2.64e-04 | 71 | 88 | 4 | int:AGPAT4 | |
| Interaction | IHH interactions | 2.80e-04 | 6 | 88 | 2 | int:IHH | |
| Interaction | PXYLP1 interactions | 3.00e-04 | 30 | 88 | 3 | int:PXYLP1 | |
| Interaction | COPB1 interactions | 3.03e-04 | 294 | 88 | 7 | int:COPB1 | |
| Cytoband | 19q13.4 | 1.54e-08 | 79 | 94 | 6 | 19q13.4 | |
| Cytoband | 7q31.3 | 4.28e-04 | 15 | 94 | 2 | 7q31.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 7.14e-04 | 195 | 94 | 4 | chr10q23 | |
| Cytoband | 11q24.1 | 2.64e-03 | 37 | 94 | 2 | 11q24.1 | |
| Cytoband | 22q13.33 | 2.78e-03 | 38 | 94 | 2 | 22q13.33 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 6.28e-11 | 18 | 73 | 6 | 620 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 7.09e-06 | 31 | 73 | 4 | 357 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.85e-04 | 394 | 73 | 8 | 471 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.68e-04 | 9 | 73 | 2 | 1203 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 7.09e-04 | 10 | 73 | 2 | 53 | |
| GeneFamily | Solute carriers | 1.06e-03 | 395 | 73 | 7 | 752 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.29e-03 | 27 | 73 | 2 | 47 | |
| GeneFamily | Actins|Deafness associated genes | 1.08e-02 | 113 | 73 | 3 | 1152 | |
| GeneFamily | MAGE family | 1.14e-02 | 40 | 73 | 2 | 1136 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | 3.07e-07 | 190 | 90 | 8 | M4662 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | 7.22e-07 | 49 | 90 | 5 | M40909 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN | 5.74e-06 | 199 | 90 | 7 | M9885 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-08 | 170 | 89 | 7 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 6.96e-07 | 155 | 89 | 6 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 169 | 89 | 6 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 172 | 89 | 6 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-06 | 173 | 89 | 6 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 174 | 89 | 6 | 2afa5eea54b67c549c5058ece98296eee3829c11 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-06 | 175 | 89 | 6 | 4655d3daa95e8ffa7d5ee4180de06b2fec361bfb | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-06 | 176 | 89 | 6 | 7d1e2627d7ec5ddd6c87c55d2a6879255b76949e | |
| ToppCell | Dendritic_Cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-06 | 178 | 89 | 6 | 61ce3ec64c4cffceac08412e20c26e9c90ab8197 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 182 | 89 | 6 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.08e-06 | 187 | 89 | 6 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.08e-06 | 187 | 89 | 6 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | Control-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 2.57e-06 | 194 | 89 | 6 | 7ab808dd1876b0eec2831caa16d04fd859b1dc50 | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.64e-06 | 195 | 89 | 6 | f1cbf82484f489fe7e0b5de6a49ea28d69f04e1a | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.64e-06 | 195 | 89 | 6 | 13168c9632b58dd65ecb365df3832d95e7325919 | |
| ToppCell | Healthy_Control-Myeloid-mDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.64e-06 | 195 | 89 | 6 | 32f505b2c24f4386367706b775e79271f99156f2 | |
| ToppCell | proximal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.64e-06 | 195 | 89 | 6 | 36b2e754ed7ff138ac05fb51f4494e5339669828 | |
| ToppCell | Control-Myeloid-MoAM4|Control / Condition, Lineage and Cell class | 2.64e-06 | 195 | 89 | 6 | 211a736acbe875bd3c1942c62aaacc9b170ece6d | |
| ToppCell | Healthy_Control-Myeloid-mDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.64e-06 | 195 | 89 | 6 | d9a6fc7fa0047472821e1dcf0962ccb3f061313e | |
| ToppCell | distal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-06 | 196 | 89 | 6 | 14c6870d125fc2bdacf4199883399cec0dd3f569 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.97e-06 | 199 | 89 | 6 | 80c8641cfd84436eadf2234f1313749e2f73331f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.22e-06 | 137 | 89 | 5 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-05 | 143 | 89 | 5 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 145 | 89 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-05 | 145 | 89 | 5 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.12e-05 | 146 | 89 | 5 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 1.16e-05 | 147 | 89 | 5 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 152 | 89 | 5 | b2e29fbda6b5f2d87cfc05423caf9cbf3b04ac65 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.50e-05 | 155 | 89 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 158 | 89 | 5 | e0b862e4b9ebaa12869640b5d18d5fa852861bef | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 1.69e-05 | 159 | 89 | 5 | e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-05 | 162 | 89 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-05 | 163 | 89 | 5 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 164 | 89 | 5 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 164 | 89 | 5 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 166 | 89 | 5 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-05 | 167 | 89 | 5 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 167 | 89 | 5 | f33cef917fa733adf6d5a9a9e989a4d9fd462a8f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 168 | 89 | 5 | d6078e3a79d315d6090906e171a7d67a9206b2c7 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 168 | 89 | 5 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 168 | 89 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 168 | 89 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 168 | 89 | 5 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.27e-05 | 169 | 89 | 5 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 169 | 89 | 5 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 169 | 89 | 5 | 9c9bb1b32fc6e22359424a262178906c3954415d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-05 | 170 | 89 | 5 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 171 | 89 | 5 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 171 | 89 | 5 | 06fe7eeffc6e0735342b88e1d1ae26a9b477fece | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.47e-05 | 172 | 89 | 5 | 9befd44bce43eb5dc1fe3d2e44608f442cf74a47 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 172 | 89 | 5 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-05 | 172 | 89 | 5 | eaba10a4d4eaab42ad2e2da65ebb20b50edaf815 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-05 | 173 | 89 | 5 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.54e-05 | 173 | 89 | 5 | 71dc0051c87b84e3cf13cde8858166f2a474b5dc | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 173 | 89 | 5 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.61e-05 | 174 | 89 | 5 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-05 | 174 | 89 | 5 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.75e-05 | 176 | 89 | 5 | 7b5e50eb144bf43ca0cf354a466eb58b976a79f1 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.75e-05 | 176 | 89 | 5 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 177 | 89 | 5 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 2.83e-05 | 177 | 89 | 5 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-05 | 178 | 89 | 5 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 178 | 89 | 5 | 8c5e9fab7b55a654ccaabf2c4d02397399d94616 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-05 | 178 | 89 | 5 | ec6364432d37a32f5152d36d89f5e96dddb72a9d | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 179 | 89 | 5 | 33ed9270d257895ff3b40df2c1af878119c9f492 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 179 | 89 | 5 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 179 | 89 | 5 | 55fde77dae7f9e7f3431c3185d14212a25af83df | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 179 | 89 | 5 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.07e-05 | 180 | 89 | 5 | a0b35067b6f2dbd8145da8bab760e9f650f045b0 | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 180 | 89 | 5 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 3.07e-05 | 180 | 89 | 5 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 181 | 89 | 5 | 092a971661b0aa06c1cdf428dbfa7339a26fb678 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 182 | 89 | 5 | 9465238ac806fce46dfe1a141e83893f23eb4afb | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 183 | 89 | 5 | f524501dec1dccbf44100a61395116e4525bdc89 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.32e-05 | 183 | 89 | 5 | 745271bfe15e94a58157cd97d771e610f964341b | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 183 | 89 | 5 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 183 | 89 | 5 | 107cc756c45d6e92181659868d91188814dae66d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 185 | 89 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 185 | 89 | 5 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.49e-05 | 185 | 89 | 5 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 185 | 89 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 185 | 89 | 5 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 185 | 89 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.49e-05 | 185 | 89 | 5 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.49e-05 | 185 | 89 | 5 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.49e-05 | 185 | 89 | 5 | ed7b26bdebfd0df2b4f5020a855a052d94ae7219 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 186 | 89 | 5 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-05 | 187 | 89 | 5 | 3748203b62abf51b74dfcfc4f18b3ba831b63a96 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.68e-05 | 187 | 89 | 5 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 3.77e-05 | 188 | 89 | 5 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.77e-05 | 188 | 89 | 5 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.81e-05 | 94 | 89 | 4 | d78535a7a0fda7299b01912333b944dc5e0a0361 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.81e-05 | 94 | 89 | 4 | dfc3f7977b9df433009d1d2d465b64a2de5806e2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 189 | 89 | 5 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| Computational | Genes in the cancer module 146. | 1.81e-04 | 102 | 56 | 5 | MODULE_146 | |
| Computational | Genes in the cancer module 27. | 4.65e-04 | 355 | 56 | 8 | MODULE_27 | |
| Computational | Genes in the cancer module 134. | 4.92e-04 | 30 | 56 | 3 | MODULE_134 | |
| Computational | T-cell proliferation genes. | 8.47e-04 | 36 | 56 | 3 | MODULE_521 | |
| Computational | Genes in the cancer module 288. | 9.18e-04 | 37 | 56 | 3 | MODULE_288 | |
| Computational | Genes in the cancer module 46. | 9.22e-04 | 394 | 56 | 8 | MODULE_46 | |
| Drug | sodium | GPR89B DPP4 EGF SLC12A4 SLC17A3 HTR7 SLC38A4 SCN4A SCN9A GRID1 SLC7A11 SLC4A5 ANKH ADCY2 ADCY5 CHRNB2 RYR1 SLC5A1 | 3.62e-08 | 944 | 92 | 18 | CID000000923 |
| Drug | isopentenyl diphosphate | 7.34e-08 | 89 | 92 | 7 | CID000001195 | |
| Drug | potassium | GPR89B EGF SLC12A4 HTR7 SV2B SLC38A4 SCN4A CLIC3 SCN9A S1PR2 PANX2 PTCH1 SLC7A11 ADCY2 ADCY5 CHRNB2 RYR1 SLC5A1 | 9.72e-08 | 1008 | 92 | 18 | CID000000813 |
| Drug | Chlorine | 2.75e-07 | 367 | 92 | 11 | ctd:D002713 | |
| Drug | Aa1 | 1.08e-06 | 83 | 92 | 6 | CID009549188 | |
| Drug | tetracaine | 1.53e-06 | 88 | 92 | 6 | CID000005411 | |
| Drug | fluphenazine | 2.26e-06 | 94 | 92 | 6 | CID000003372 | |
| Drug | forskolin from Coleus forskohlii | LHCGR VIPR1 EGF HTR7 SLC38A4 SCN4A SCN9A S1PR2 PTCH1 ADCY2 ADCY5 CHRNB2 RYR1 EDNRB SLC5A1 GLP2R | 2.74e-06 | 1013 | 92 | 16 | CID000003413 |
| Drug | verapamil | BOC CYP2C9 EGF HTR7 ABCA12 SCN4A SCN9A ADCY2 ADCY5 CHRNB2 RYR1 | 4.59e-06 | 490 | 92 | 11 | CID000002520 |
| Drug | AC1L1CBF | 8.84e-06 | 336 | 92 | 9 | CID000001822 | |
| Drug | NO-cAMP | 8.85e-06 | 69 | 92 | 5 | CID006426615 | |
| Drug | phosphatidate | 9.82e-06 | 432 | 92 | 10 | CID005460104 | |
| Drug | Substance P | 1.04e-05 | 343 | 92 | 9 | CID000036511 | |
| Drug | atropine sulfate | 1.14e-05 | 347 | 92 | 9 | CID000003661 | |
| Drug | 8-bromo-cAMP | 1.18e-05 | 264 | 92 | 8 | CID000001912 | |
| Drug | 2-nitro-p-cresol | 1.42e-05 | 76 | 92 | 5 | CID000008391 | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 1.54e-05 | 197 | 92 | 7 | 4152_UP | |
| Drug | Phenyl chloroformate | 1.62e-05 | 2 | 92 | 2 | CID000015891 | |
| Drug | chloroquine | 2.21e-05 | 288 | 92 | 8 | CID000002719 | |
| Drug | trans-permethrin | 2.60e-05 | 86 | 92 | 5 | CID000040159 | |
| Drug | GTP[S] | VIPR1 RECQL5 SCN4A SCN9A ADCY2 ADCY5 RYR1 ARF1 ARF3 ARF4 ARF5 | 2.64e-05 | 591 | 92 | 11 | CID000001764 |
| Drug | GI-3 | 2.95e-05 | 147 | 92 | 6 | CID011957433 | |
| Drug | Men 10627 | 3.44e-05 | 16 | 92 | 3 | CID006438356 | |
| Drug | nsc25485 | 3.90e-05 | 312 | 92 | 8 | CID000004605 | |
| Drug | nM-1 | 3.98e-05 | 155 | 92 | 6 | CID000445754 | |
| Drug | Ozone | VIPR1 DPP4 RIPOR2 SV2B SLC38A4 SCN4A S1PR2 SLC7A11 ADCY2 ADCY5 EDNRB ARF1 ARF3 ARF4 SLC5A1 ARF5 | 4.67e-05 | 1273 | 92 | 16 | ctd:D010126 |
| Drug | lidocaine | 4.75e-05 | 160 | 92 | 6 | CID000003676 | |
| Drug | Sc 58272 | 4.83e-05 | 3 | 92 | 2 | CID000446385 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 4.83e-05 | 3 | 92 | 2 | ctd:C561228 | |
| Drug | 4 OM | 4.83e-05 | 3 | 92 | 2 | CID000001754 | |
| Drug | SK&F 82958 | 5.90e-05 | 19 | 92 | 3 | ctd:C071262 | |
| Drug | iodide | 5.96e-05 | 534 | 92 | 10 | CID000024841 | |
| Drug | methanethiosulfonate | 6.18e-05 | 103 | 92 | 5 | CID004188587 | |
| Drug | propranolol | 6.57e-05 | 434 | 92 | 9 | CID000004946 | |
| Drug | fenoterol | 7.81e-05 | 56 | 92 | 4 | CID000003343 | |
| Drug | orphenadrine | 7.81e-05 | 56 | 92 | 4 | CID000004601 | |
| Drug | cyanopindolol | 8.37e-05 | 57 | 92 | 4 | CID000155346 | |
| Drug | AC1NE3N8 | 8.58e-05 | 178 | 92 | 6 | CID004636050 | |
| Drug | carbamazepine | 8.85e-05 | 179 | 92 | 6 | CID000002554 | |
| Drug | cisapride | 9.21e-05 | 112 | 92 | 5 | CID000002769 | |
| Drug | D-pyroglutamate | 9.21e-05 | 112 | 92 | 5 | CID000000499 | |
| Drug | BP-1,6-quinone | 9.30e-05 | 22 | 92 | 3 | CID000018300 | |
| Drug | AZD 1480 | 9.64e-05 | 4 | 92 | 2 | ctd:C545606 | |
| Drug | myo-inositol | LHCGR DPAGT1 VIPR1 EGF HTR7 S1PR2 ADCY2 ADCY5 RYR1 EDNRB ARF1 SLC5A1 | 1.02e-04 | 811 | 92 | 12 | CID000000892 |
| Drug | estrone sulfate | 1.07e-04 | 23 | 92 | 3 | ctd:C017296 | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.09e-04 | 186 | 92 | 6 | 2218_UP | |
| Drug | zonisamide | 1.16e-04 | 62 | 92 | 4 | CID000005734 | |
| Drug | AC1L1AQK | 1.23e-04 | 119 | 92 | 5 | CID000001105 | |
| Drug | Ebselen [60940-34-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.23e-04 | 190 | 92 | 6 | 3458_UP | |
| Drug | NSC759576 | 1.26e-04 | 191 | 92 | 6 | CID000003075 | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.34e-04 | 193 | 92 | 6 | 2283_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; HL60; HT_HG-U133A | 1.38e-04 | 194 | 92 | 6 | 2741_DN | |
| Drug | CDK2 Inhibitor II | 1.40e-04 | 65 | 92 | 4 | CID005858639 | |
| Drug | probenecid | 1.43e-04 | 123 | 92 | 5 | CID000004911 | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 1.45e-04 | 196 | 92 | 6 | 3930_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 5565_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 6061_DN | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 4305_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 3339_UP | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 4286_UP | |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 4594_UP | |
| Drug | PbTx-2 | 1.55e-04 | 26 | 92 | 3 | CID000002432 | |
| Drug | pipecolamide | 1.60e-04 | 5 | 92 | 2 | CID000140623 | |
| Drug | 1c88 | 1.60e-04 | 126 | 92 | 5 | CID000444766 | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A | 1.62e-04 | 200 | 92 | 6 | 3760_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.62e-04 | 200 | 92 | 6 | 3713_DN | |
| Drug | AC1MBZ1C | 1.74e-04 | 387 | 92 | 8 | CID000003541 | |
| Drug | dl-Lysine | 1.76e-04 | 290 | 92 | 7 | CID000000866 | |
| Drug | encainide | 1.94e-04 | 28 | 92 | 3 | CID000048040 | |
| Drug | Nocloprostum | 1.94e-04 | 28 | 92 | 3 | CID006435380 | |
| Drug | T2755 | 1.97e-04 | 71 | 92 | 4 | CID000005514 | |
| Drug | synthetic pyrethrins | 1.97e-04 | 71 | 92 | 4 | CID000002982 | |
| Drug | NSC237521 | 2.11e-04 | 210 | 92 | 6 | CID000428410 | |
| Drug | tolazoline | 2.16e-04 | 29 | 92 | 3 | CID000005504 | |
| Drug | difluoromethylene | 2.16e-04 | 29 | 92 | 3 | CID006432238 | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 2.20e-04 | 73 | 92 | 4 | CID011963505 | |
| Drug | oxcarbazepine | 2.40e-04 | 30 | 92 | 3 | CID000034312 | |
| Drug | histidinoalanine | 2.40e-04 | 30 | 92 | 3 | CID000444509 | |
| Drug | AC1L4JRE | 2.40e-04 | 6 | 92 | 2 | CID000158343 | |
| Drug | Calix[6]arene | 2.40e-04 | 6 | 92 | 2 | CID002724885 | |
| Drug | 2-hydroxy-1-(2-((9-(4-methylcyclohexyl)-9H-pyrido(4',3'-4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)ethanone | 2.40e-04 | 6 | 92 | 2 | ctd:C000589290 | |
| Drug | monoethylfumarate | 2.40e-04 | 6 | 92 | 2 | CID000041331 | |
| Drug | Ts-I | 2.44e-04 | 75 | 92 | 4 | CID000445278 | |
| Drug | chloride | BOC SLC12A4 SLC17A3 HTR7 ACR SCN4A CLIC3 GRID1 SLC4A5 ADCY2 ADCY5 SLC5A1 ARF5 | 2.47e-04 | 1029 | 92 | 13 | CID000000312 |
| Drug | epicholesterol | 2.48e-04 | 636 | 92 | 10 | CID000000304 | |
| Drug | CF3CO | 2.64e-04 | 31 | 92 | 3 | CID000123237 | |
| Drug | quindine | 2.65e-04 | 219 | 92 | 6 | CID000001065 | |
| Drug | phenytoin | 2.65e-04 | 219 | 92 | 6 | CID000001775 | |
| Drug | AC1L1H5B | 2.70e-04 | 77 | 92 | 4 | CID000003981 | |
| Drug | D-Au | 2.70e-04 | 77 | 92 | 4 | CID000277822 | |
| Drug | guanine | LHCGR VIPR1 S1PR2 GRID1 ADCY2 ADCY5 EDNRB ARF1 ARF3 ARF4 GLP2R ARF5 | 2.74e-04 | 902 | 92 | 12 | CID000000764 |
| Drug | alpha-bromoergocriptine | 2.80e-04 | 142 | 92 | 5 | CID000002443 | |
| Drug | Peptavlon | 2.83e-04 | 78 | 92 | 4 | CID000021701 | |
| Drug | bunazosin | 2.91e-04 | 32 | 92 | 3 | CID000002472 | |
| Drug | Betamethasone-d5 | BOC LHCGR RIPOR2 CYP2C9 EGF HTR7 ACR SCN4A SCN9A ADCY2 ADCY5 CHRNB2 EDNRB STAT5A SLC5A1 | 2.95e-04 | 1340 | 92 | 15 | CID000003003 |
| Drug | salbutamol | 3.18e-04 | 146 | 92 | 5 | CID000002083 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 8.80e-06 | 14 | 87 | 3 | EFO_0004307, EFO_0008464 | |
| Disease | B-lymphoblastic leukemia/lymphoma (is_marker_for) | 5.14e-05 | 4 | 87 | 2 | DOID:0080630 (is_marker_for) | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 5.14e-05 | 4 | 87 | 2 | 605462 | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 5.14e-05 | 4 | 87 | 2 | cv:C2751544 | |
| Disease | Oculo-dento-digital syndrome | 5.14e-05 | 4 | 87 | 2 | C0812437 | |
| Disease | Malignant neoplasm of breast | BOC LHCGR DPAGT1 MAGEA4 EGF PANX2 TECTA PCDH20 RNF182 EDNRB ARF1 STAT5A | 7.30e-05 | 1074 | 87 | 12 | C0006142 |
| Disease | Hereditary hearing loss and deafness | 7.38e-05 | 146 | 87 | 5 | cv:C0236038 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 7.69e-05 | 28 | 87 | 3 | DOID:3717 (is_marker_for) | |
| Disease | Basal Cell Nevus Syndrome | 8.54e-05 | 5 | 87 | 2 | C0004779 | |
| Disease | Sleep Disorders | 1.79e-04 | 7 | 87 | 2 | C0851578 | |
| Disease | Subwakefullness Syndrome | 1.79e-04 | 7 | 87 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 1.79e-04 | 7 | 87 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 1.79e-04 | 7 | 87 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 1.79e-04 | 7 | 87 | 2 | C0751508 | |
| Disease | Sleep Wake Disorders | 1.79e-04 | 7 | 87 | 2 | C4042891 | |
| Disease | glucagon-like peptide-1 measurement, glucose tolerance test | 2.38e-04 | 8 | 87 | 2 | EFO_0004307, EFO_0008465 | |
| Disease | Anxiety States, Neurotic | 3.00e-04 | 44 | 87 | 3 | C0376280 | |
| Disease | Anxiety Disorders | 3.00e-04 | 44 | 87 | 3 | C0003469 | |
| Disease | Anxiety neurosis (finding) | 3.00e-04 | 44 | 87 | 3 | C1279420 | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 3.05e-04 | 9 | 87 | 2 | DOID:635 (is_implicated_in) | |
| Disease | Gastrointestinal Stromal Sarcoma | 3.65e-04 | 47 | 87 | 3 | C3179349 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 3.81e-04 | 10 | 87 | 2 | EFO_0008200 | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Tumors | 4.39e-04 | 50 | 87 | 3 | C0238198 | |
| Disease | Basal cell carcinoma | 4.65e-04 | 11 | 87 | 2 | C0007117 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 5.56e-04 | 12 | 87 | 2 | C0270960 | |
| Disease | basal cell carcinoma (is_implicated_in) | 5.56e-04 | 12 | 87 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | body weights and measures, parental genotype effect measurement | 7.64e-04 | 14 | 87 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 8.80e-04 | 15 | 87 | 2 | EFO_0800301 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.00e-03 | 16 | 87 | 2 | C0751885 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 1.00e-03 | 16 | 87 | 2 | EFO_0800305 | |
| Disease | diabetes mellitus | 1.08e-03 | 68 | 87 | 3 | EFO_0000400 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.14e-03 | 17 | 87 | 2 | C0751883 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.22e-03 | 157 | 87 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 36:4 measurement | 1.28e-03 | 18 | 87 | 2 | EFO_0010382 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.38e-03 | 74 | 87 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Colorectal Neoplasms | 1.39e-03 | 277 | 87 | 5 | C0009404 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.42e-03 | 19 | 87 | 2 | C0751884 | |
| Disease | Nonsyndromic genetic hearing loss | 1.49e-03 | 76 | 87 | 3 | cv:C5680182 | |
| Disease | Nonsyndromic Deafness | 1.79e-03 | 81 | 87 | 3 | C3711374 | |
| Disease | Attention Deficit Disorder | 1.91e-03 | 22 | 87 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.91e-03 | 22 | 87 | 2 | C1321905 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.91e-03 | 22 | 87 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Neoplasm Invasiveness | 2.18e-03 | 184 | 87 | 4 | C0027626 | |
| Disease | Myasthenic Syndromes, Congenital | 2.27e-03 | 24 | 87 | 2 | C0751882 | |
| Disease | Attention deficit hyperactivity disorder | 2.27e-03 | 24 | 87 | 2 | C1263846 | |
| Disease | dental caries | 2.31e-03 | 187 | 87 | 4 | EFO_0003819 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 2.67e-03 | 26 | 87 | 2 | DOID:234 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.68e-03 | 195 | 87 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | gout | 2.73e-03 | 196 | 87 | 4 | EFO_0004274 | |
| Disease | glucose tolerance test | 2.88e-03 | 27 | 87 | 2 | EFO_0004307 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILGVPLIIFTIKANS | 36 | Q10589 | |
| PTAILLVLAVSVVAK | 6 | P10323 | |
| VLLLKGVPFTLTTVD | 31 | O95833 | |
| IFIILAITRTKFPPT | 36 | Q86UK0 | |
| KLKLGEIVTTIPTIG | 36 | P84085 | |
| GSGVPVVLITTLLVI | 861 | P19021 | |
| KLKLGEIVTTIPTIG | 36 | P61204 | |
| LVPFIQKASVGITVL | 176 | P24530 | |
| GFLIALPILIVTTAI | 686 | Q8TC27 | |
| LKVVTPIIISVFVLA | 986 | O95622 | |
| SGSLPVFVVVVLVLL | 651 | P78325 | |
| IGSIVLAIIVPSLLL | 301 | P29016 | |
| TPLVAITITRLVVGF | 331 | Q16581 | |
| PISLLVTLEVVKFTQ | 356 | Q9Y2Q0 | |
| VLIGTSVVKIPFTIL | 246 | P43631 | |
| SRPLKVLLTVVIVFI | 236 | Q9NPB9 | |
| SLSCIIILPTIIVII | 226 | Q8NGE7 | |
| IPAVITALVSIIKVI | 406 | Q8N6Y1 | |
| LITVRKIATILGSLP | 286 | O00476 | |
| VTGVTFLLLPISAIV | 201 | A6NM03 | |
| VLIGTSVVKIPFTIL | 246 | P43632 | |
| VPLITVTNSKVLLVL | 596 | P22888 | |
| IFPKTGLLIIVLGTI | 196 | P43358 | |
| VPKTGLLIIVLAIIA | 196 | P43365 | |
| LVQFVKSITLPVILV | 211 | A6NDA9 | |
| IVSLLGFVATVTLIP | 16 | Q9H3H5 | |
| IIILIFVLSAVVPDK | 256 | Q6P1Q9 | |
| TVLTIPEIIIKVRGT | 626 | P00488 | |
| FVSGVIVKIISTEPL | 451 | Q4G0J3 | |
| VLIGTSVVKLPFTIL | 246 | Q14952 | |
| ALVTIITVPVVLLNK | 16 | P27487 | |
| KAVIPLVIVSALTFI | 1636 | P23471 | |
| VATTLFILTPLLLII | 201 | Q8NGS9 | |
| IPKLLGTFVVARTVI | 76 | Q8NH79 | |
| VLIGTSVVKLPFTIL | 246 | Q14953 | |
| IVQILVLPKTSVLGI | 616 | Q08462 | |
| PFLTLVLLVSIKQVT | 51 | O95838 | |
| VLGSIVLIIVTFIPF | 861 | Q9BWV1 | |
| IIVTSIRGLLITLTK | 351 | B7ZAQ6 | |
| IIVTSIRGLLITLTK | 351 | P0CG08 | |
| IILLPVVSKFSFVSL | 6 | P01133 | |
| KTFVLAPSSVLRIIV | 396 | Q9HCJ1 | |
| KLKLGEIVTTIPTIG | 36 | P84077 | |
| GLTLKVVTVLEEPFV | 436 | Q9ULK0 | |
| IPKGTTILISLTSVL | 381 | P11712 | |
| LVGTFVSPEVFLKLI | 426 | Q86Y56 | |
| PQTLALLKTVTIVLG | 226 | O95136 | |
| FQFVPVLKLVSTLLV | 1836 | P21817 | |
| TVLKTIVLIPCIGVL | 86 | O43908 | |
| IIVGSIITKCSIPVL | 306 | Q13895 | |
| ITVISLVLILIVAPK | 216 | Q6NVV3 | |
| IGTVLVPILLVTLVF | 56 | Q96RD6 | |
| VLIGTSVVKIPFTIL | 246 | Q14954 | |
| LGIVIIVRTLVFVTP | 146 | Q8NH55 | |
| KSVVLVIVLGPLVFL | 126 | P0DTE0 | |
| ALKTITVIPGLKTIV | 226 | P35499 | |
| ASFVGITKVVPILLA | 646 | Q7L1I2 | |
| ITKVVPILLAAASLV | 651 | Q7L1I2 | |
| TPKVVLILGTSILDL | 326 | Q9BXQ6 | |
| LTGRTVAIPVKVIAI | 456 | Q6IEE7 | |
| ISIIIVLVATGIIFK | 186 | Q8IYJ0 | |
| GIKLSAIPVVILVAS | 1011 | Q9Y6C5 | |
| ILIGTSVVKIPFTIL | 341 | Q14943 | |
| IKLSAVPVVILIASV | 1076 | Q13635 | |
| PITVTLFGKAILRIL | 356 | Q9BX95 | |
| ALKTISVIPGLKTIV | 221 | Q15858 | |
| VFLPLQIVGVTLLTL | 186 | P08842 | |
| LLRTSVTVKVVIIPP | 1026 | O60292 | |
| VFQVKTLSLPVVVIV | 456 | P51692 | |
| FSFLELLLVTVVVPK | 66 | Q8NGN1 | |
| LGVVFVSLVPSSLVI | 211 | Q8N6D2 | |
| LIIFVSVGIILPLSL | 201 | Q969I6 | |
| VSKIVSTLLFILVPV | 271 | Q5PT55 | |
| STLLFILVPVSIGIV | 276 | Q5PT55 | |
| LPLIVGFISIKVTEL | 256 | Q9Y4F9 | |
| IPVGTILAIITTSLV | 451 | Q9UP95 | |
| VFQVKTLSLPVVVIV | 456 | P42229 | |
| LTVFLLLISKIVPPT | 276 | P17787 | |
| KVVIGSILTLITLLT | 81 | P34969 | |
| NITITIVVITKILRP | 1186 | Q8IZF2 | |
| KLKLGEIVTTIPTIG | 36 | P18085 | |
| ALLAKGITIVVSPLI | 66 | O94762 | |
| VTSLPVTLDLGTVKI | 406 | O75443 | |
| PELAIKLITAVGITV | 161 | Q9UPY5 | |
| ILITERSGTPILKVA | 366 | Q8TDR2 | |
| IIKGPILTSILVNFI | 296 | P32241 | |
| SISVLVPGLLLVFVT | 616 | Q96PX8 | |
| SLIPSKISTIIGILA | 1521 | Q6ZS81 | |
| VVKFLSLLQVEIPGT | 646 | Q9HBX9 | |
| IILSSTGPILIFEKL | 576 | Q9BY07 | |
| VRVSVLTPLKLVGLV | 11 | Q9BQJ4 | |
| IIKISPIILNTVLTI | 2201 | Q709C8 | |
| IIVGIFLVVTIPLTF | 1866 | P08922 | |
| AIITVVKPSTRILSI | 156 | Q9UJA5 | |
| PVLLSVGVTFILIAV | 76 | Q8WUU8 | |
| ISFITIVVISLLTKP | 536 | P13866 | |
| VLLVVTALSVPVLFL | 651 | Q9Y487 |